Saw Palmetto
EVIDENCE: WEAKAlso sold as: Serenoa repens, sabal, saw palmetto berry, S. repens extract
Large trials and the cited Cochrane review found saw-palmetto sterol extract at 320 mg daily no better than placebo for BPH symptoms. Earlier small studies were more encouraging. Essential oil and raw powder are different preparations, without the same trial record.
Compiled by iSupplementReviews editorial team ·Updated 2026-10-06 · 4 sources
- Type
- Botanical (prostate/LUTS herb)
- Studied dose
- 320 mg/day liposterolic extract (85–95% fatty acids), the dose in NEJM 2006 and Cochrane-analyzed trials
- Best form
- Liposterolic (sterol) extract 85–95% fatty acids, 320 mg — the only form studied in the landmark trials; 'essential oil' or unstandardized powders are untested preparations
- Upper limit
- No formal upper intake limit — well tolerated at 320 mg in trials up to 72 weeks
- Our rating
- WEAK — Mostly small, animal, or traditional evidence
What is saw palmetto?
Saw palmetto is a small palm native to the southeastern US whose berries are used in prostate supplements. Its proposed action involves the enzyme converting testosterone to DHT. That theory led to comparisons with finasteride, but it does not establish equivalent clinical effects.
What does the research show?
| Claim | Evidence | Dose studied | Verdict |
|---|---|---|---|
| Relieves BPH/urinary symptoms | Large trial + Cochrane meta-analysis | 320 mg/day liposterolic extract | Null at the best-evidence level — NEJM 2006 and Cochrane both found no better than placebo |
| Equivalent to finasteride | Older comparative trials | 320 mg/day | Finasteride outperforms on PSA reduction and objective measures; equivalence claims don’t survive modern review |
| Shrinks the prostate | No credible human evidence | — | No size effect in modern trials |
| Cancer support | None | — | No prevention or treatment evidence |
The strongest trials found no benefit at the tested amounts. Saw palmetto has been studied more extensively than many supplement ingredients. Its larger, better-controlled studies did not confirm the encouraging results from early small trials. That supports a conclusion about the tested preparations and regimens, rather than simply a lack of research.
How it is used in supplements
The correct studied preparation is a liposterolic extract standardized to ~85–95% fatty acids and sterols, 320 mg/day. This is what NEJM and the Cochrane-analyzed trials administered. Products using whole-berry powder, unstandardized ‘saw palmetto,’ ‘saw palmetto essential oil,’ or fractional doses inside a proprietary blend are borrowing the ingredient’s reputation without delivering the tested intervention. A 500 mg blend shared with other oils cannot credibly deliver a meaningful saw palmetto regimen.
Side effects and who should avoid it
Well tolerated in trials: placebo-comparable digestive upset and headache rates. Theoretical caution for hormone-sensitive conditions. Current evidence shows no meaningful PSA effect at studied doses, so ‘masked PSA’ is not the live concern older sources claimed. But it is still not a substitute for finasteride or dutasteride where a urologist has prescribed them.
What to know before choosing it
The best cited trials and Cochrane review found the studied sterol extract no better than placebo for BPH symptoms. Essential oil and raw powder are different preparations and do not gain evidence from those trials. Familiarity and widespread use are not proof of effectiveness.
Frequently asked questions about Saw Palmetto
Does saw palmetto work for BPH?
The strongest cited trials found no benefit over placebo. Bent et al. 2006 randomized 225 men to 320 mg daily or placebo, with no significant symptom-score difference. The Cochrane review reached the same conclusion. Earlier small trials were more encouraging but were not confirmed by stronger evidence.
Is there a difference between saw palmetto 'extract' and 'essential oil'?
A big one, and it matters on labels. The clinical trials all used a liposterolic extract standardized to ~85–95% fatty acids/sterols. An 'essential oil' (the steam-distilled volatile fraction) is a chemically different preparation with essentially no BPH trial record. A label listing 'saw palmetto essential oil' inside a blend is using the ingredient's reputation without its tested form.
Why does every prostate supplement contain it?
It's the category anchor, the name-recognition ingredient. Including it lets a formula claim 'prostate support' at almost any dose, and most consumers haven't seen the trial finding no benefit results. It's also cheap, stable, and safe: a low-risk marketing inclusion.
Is saw palmetto safe?
Very. The trials show placebo-like tolerability: mild digestive upset occasionally. A theoretical mild anti-androgen effect means it's sometimes flagged for hormone-sensitive conditions, but clinically significant interactions are rarely documented. Finasteride users: no evidence it substitutes for or adds to prescription therapy.
Does it lower PSA or help prostate cancer?
Modern trials say it does neither meaningfully. The 2011 JAMA dose-escalation trial found no PSA advantage even at triple the standard dose, and NCCIH's current guidance is that saw palmetto does not appear to affect PSA readings. The 'masks PSA' worry mostly traces to PC-SPES, a different multi-herb product, not saw palmetto itself. It also doesn't shrink the prostate or prevent cancer.
References
- [1]Bent S et al. — Saw palmetto for benign prostatic hyperplasia (NEJM 2006;354:557-66) — the landmark null RCT
- [2]Tacklind J et al. — Serenoa repens for BPH, Cochrane review (updated through 2012) — no better than placebo at escalating doses
- [3]Tacklind J et al. — Serenoa repens (saw palmetto) for BPH, Cochrane systematic review (CD001423, 2012) — the efficacy evidence
- [4]Barry MJ et al. — Saw palmetto extract up to 3× standard dose vs placebo for LUTS (JAMA, 2011) — no PSA or symptom advantage
Products we reviewed containing Saw Palmetto
Based on recorded labels or seller-described formulas. Inclusion does not establish a match to the strains, preparations or amounts studied here; check each review's disclosure limits.